Document is current
Any future updates will be listed below
-
Authors
Sherriff, Nigel http://orcid.org/0000-0001-5657-5047
Mirandola, Massimo
Silva, Ronaldo
Cordioli, Maddalena
Sawyer, Alexandra
Gios, Lorenzo
Zorzi, Antonella
Huber, Jorg
Vera, Jaime
Richardson, Daniel
Hassan-Ibrahim, Mohammed
Wlazly, Dominika
Padovese, Valeska
Barbara, Christopher
Darmanin, Anabel
Schembri, Aaron
Caceres, Carlos
Vargas, Silver
Blondeel, Karel
Kiarie, James
Kurbonov, Firdavs
Peeling, Rosanna W.
Thwin, Soe Soe
Toskin, Igor
,
Hançali, Amina
Oumzi, Hicham
Mwima, Simon
Kyambadde, Peter
Ssewanyana, Isaac
-
Funding
Funding for this research was provided by:
UNDP-UNFPA-UNICEF-WHO-World Bank
- License Information
-
More Information
Article History
Received: 1 August 2022
Accepted: 11 January 2024
First Online: 29 February 2024
Declarations
:
: The core protocol upon which this study was based was independently peer reviewed and approved by the Research Project Review Panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research (SRH) and by the WHO Ethics Review Committee (ERC). The protocol has also been adapted to the individual countries and approved by RP2, ERC, and institutional review boards at each site. Details are provided in the published protocol (20).
: Not applicable.
: The POCT manufacturers disclose and furnish free of charge to WHO the information and sufficient quantities of the product(s) in order to enable this evaluation as part of the WHO/RHR STI POC initiative. WHO is entitled to evaluate and publish the trial results, and to exclusively control this evaluation and the content of the aforesaid publication. WHO shall submit any proposed publication to the manufacturers for review, comments received will be considered in good faith, but the decision to publish rests with WHO.
